🇺🇸 FDA
Patent

US 8962026

Nanoemulsion therapeutic compositions and methods of using the same

granted A61KA61K31/045A61K31/047

Quick answer

US patent 8962026 (Nanoemulsion therapeutic compositions and methods of using the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/045, A61K31/047, A61K31/14, A61K31/198